Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)

Authors: Jyoti D. Patel, Ju-Whei Lee, David P. Carbone, Henry Wagner, Anil Shanker, Maria Teresa P. de Aquino, Leora Horn, Melissa L. Johnson, David E. Gerber, Jane Jijun Liu, Millie Das, Mohammed Ali Al-Nsour, Christopher Dakhil, Suresh S. Ramalingam, Joan H. Schiller - Clinical Lung Cancer 2020 cited by 23